SOURCE: Industrial Info Resources

Industrial Info Resources

January 11, 2016 07:30 ET

Pharma-Biotech Capital Construction 2015 Investment Review: $15 Billion in 2015 Project Kick-Offs, an Industrial Info News Alert

SUGAR LAND, TX--(Marketwired - Jan 11, 2016) - Reported by Annette Kreuger, Industrial Info Resources (Sugar Land, Texas) -- With 2016 in its earliest days, let's take look back at some of the high points in 2015. A recent analysis of reported projects that began in 2015, derived from Industrial Info's Pharmaceutical-Biotech Online Database, has revealed that the North American Pharmaceutical & Biotech Industry kicked off a healthy $15 billion worth of construction activity.

Within this article: Frederick, Maryland manufacturing center expansion by AstraZeneca (NYSE:AZN) and intravenous biologics plant project by Gilead Sciences (NASDAQ:GILD).

For details, view the entire article by subscribing to Industrial Info's Premium Industry News, or browse other breaking industrial news stories at

Industrial Info Resources (IIR), with global headquarters in Sugar Land, Texas, five offices in North America and 10 international offices, is the leading provider of global market intelligence specializing in the industrial process, heavy manufacturing and energy markets. Industrial Info's quality-assurance philosophy, the Living Forward Reporting Principle™, provides up-to-the-minute intelligence on what's happening now, while constantly keeping track of future opportunities. To contact an office in your area, visit the "Contact Us" page.

Contact Information

  • Contact:
    Brian Ford